ChemoMetec ASOCSE:CHEMM +0.38%99 FCF Yield % is 2.06 as of Jun. 28, 2026, which is 164% above its 10-year median of 0.78. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr523.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 855 Medical Devices & Instruments companies, ChemoMetec AS ranks better than 65.15% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for ChemoMetec AS's FCF Yield % or its related term are showing as below:
OCSE:CHEMM'
s FCF Yield % Range Over the Past 10 Years
Min: -2.51 Med: 0.78 Max: 2.83
Current: 2.06
During the past 13 years, the highest FCF Yield % of ChemoMetec AS was 2.83%. The lowest was -2.51%. And the median was 0.78%.
OCSE:CHEMM's FCF Yield % is ranked better than 65.15% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs OCSE:CHEMM: 2.06
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
ChemoMetec AS FCF Yield % Related Terms
ChemoMetec AS FCF Yield % Historical Data
* Premium members only.
The historical data trend for ChemoMetec AS's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:CHEMM vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, ChemoMetec AS's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's FCF Yield % distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (OCSE:CHEMM) has a FCF Yield % of 2.06 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on ChemoMetec AS and its competitors. This is 164% above median its historical median of 0.78. According to the industry distribution chart, ChemoMetec AS ranks #298 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 34.9%.
Is ChemoMetec AS's FCF Yield % too high?
ChemoMetec AS's current FCF Yield % of 2.06 is 164% above median its 10-year median of 0.78. Based on the distribution chart, ChemoMetec AS ranks #298 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #298 out of 855 companies for FCF Yield %. This puts ChemoMetec AS in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on ChemoMetec AS and its competitors. ChemoMetec AS's current FCF Yield % is 2.06, which is 164% above median its own 10-year median of 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr523.33, compared to a current price of kr370.60 — trading 29.2% below its estimated fair value. The current FCF Yield % is 2.06, which is 164% above median its 10-year median of 0.78. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current FCF Yield % is 2.06 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of kr370.60 is trading 29.2% below its estimated GF Value™ of kr523.33.
GuruFocus considers ChemoMetec AS to be Modestly Undervalued.
Key valuation signals for OCSE:CHEMM:
FCF Yield %: 2.06 (164% above median its 10-year median of 0.78)
GF Value™: kr523.33 vs. price of kr370.60 (29.2% below fair value)
No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for OCSE:CHEMM
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:CHEMM has been successfully added to your 
